Eyes and vision, Planning

Applied filters

Guidance (44)
- Advanced therapy medicinal products (16)
- Safety in Breastfeeding (25)
- Stability in dosette boxes (10)
- Stability outside the fridge (12)
Medicine (67)
- Aciclovir (1)
- Adalimumab (1)
- Aflibercept (1)
- Apraclonidine (1)
- Azithromycin (1)
- Bevacizumab (1)
- Bimatoprost (1)
- Brimonidine (1)
- Brimonidine + Timolol (1)
- Brinzolamide (1)
- Brinzolamide + Timolol (1)
- Brolucizumab (1)
- Bromfenac (1)
- Ciclosporin (1)
- Ciprofloxacin (1)
- Dexamethasone (2)
- Dorzolamide (1)
- Dorzolamide + Timolol (1)
- Eculizumab (1)
- Fluocinolone acetonide (1)
- Idebenone (1)
- Ketorolac (1)
- Latanoprost (1)
- Latanoprost + Timolol (1)
- Levobunolol (1)
- Levofloxacin (1)
- Lidocaine (1)
- Lodoxamide (1)
- Loteprednol (1)
- Mercaptamine (1)
- Mitomycin (1)
- Moxifloxacin (1)
- Naphazoline (1)
- Nedocromil (1)
- Nepafenac (1)
- Netilmicin (2)
- Ocriplasmin (1)
- Olopatadine (1)
- Pegaptanib (1)
- Ranibizumab (1)
- Ravulizumab (1)
- Rimexolone (1)
- Sirolimus (1)
- Tafluprost (1)
- Tobramycin (1)
- Travoprost (1)
- Triamcinolone acetonide (1)
- Varenicline (1)
- Verteporfin (1)
- Voretigene neparvovec (1)
Planning (91)
- Biosimilars (4)
- New Medicines (66)
  - CCG commissioned new medicines (38)
  - NHS England commissioned new medicines (30)
  - Pre-registration new medicines (UK/EU) (6)
- Patent expiries (37)
Specialty (91)
- Allergy and immunology (2)
- Anaesthesia and pain (2)
- Cancers (6)
- Cardiovascular system disorders (2)
- Ear, nose and throat disorders (3)
- Endocrine system disorders (1)
- Eyes and vision (91)
- Gastrointestinal disorders (2)
- Haematological disorders (4)
- Infection and infectious diseases (7)
- Mental health and illness (2)
- Musculo-skeletal disorders (6)
- Nutritional and metabolic disorders (2)
- Respiratory disorders (2)
- Skin disorders (8)